Sign inJoin waitlistJoin the waitlist

Tait Shanafelt

Chief Wellness Officer, Stanford Medicine · Stanford Health Care

Credentials: · · · · · ·

History

Stanford School of Medicine · Stanford Health Care
Present
Stanford Health Care
Present
Stanford Health Care
Present

Hematology and Medical Oncology
2022–2025
Pediatric Hospital Medicine
Stanford Health Care
2020–2022
University of Washington Medical Center Dept of Medicine (2001) WA
1998–2001
Stanford University School of Medicine
1994–1998
Brown University

Research

Burnout and satisfaction with work-life balance among US physicians relative to the general US population
Archives of Internal Medicine · 2012 · First of 9 authors · Corresponding · 2,316 citations
Physician burnout: contributors, consequences and solutions
Review · Journal of Internal Medicine · 2018 · Last of 3 authors · 1,860 citations
Changes in Burnout and Satisfaction With Work-Life Balance in Physicians and the General US Working Population Between 2011 and 2014
Mayo Clinic Proceedings · 2015 · First of 7 authors · Corresponding · 1,738 citations

Neil Kay
172 papers
TC
Timothy Call
117 papers
Liselotte Dyrbye
108 papers
Colin West
95 papers
Mickey Trockel
78 papers
CS
Christine Sinsky
64 papers
Sameer Parikh
61 papers
Curtis Hanson
56 papers
Clive Zent
54 papers
JL
Jose Leis
47 papers
WD
Wei Ding
39 papers
Thomas Habermann
21 papers

Grants

Outcomes for CLL Patients Treated with Novel Therapy
National Cancer Institute · R01
PI · $4M · Mayo Clinic Rochester
2021–2031
Molecular Detection of MBL and Enhanced Risk Stratification Through Immunogenetic and Proteomic Profiling.
National Cancer Institute · R01
PI · $511.6K · Erasmus Medical Center
2026–2031
Prevalence, Etiology, and Clinical Implications of Low Count Monoclonal B-Cell Lymphocytosis (MBL)
National Institute on Aging · RF1
PI · $3.4M · Mayo Clinic Rochester
2018–2029
Prevalence, Etiology, and Clinical Implications of Low Count Monoclonal B-Cell Lymphocytosis (MBL)
National Institute on Aging · R01
PI · $3.2M · Mayo Clinic Rochester
2018–2023

Clinical trials

Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2019–2028
Performance Nutrition for Residents and Fellows
Principal investigator · Completed
Stanford University
2018–2019
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
Principal investigator · Terminated · Phase 2
Mayo Clinic
2015–2017
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2014–2026